Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DXCM

Dexcom Inc

Mar 13 • 01:27PM ET

68.53

Dollar change -2.23
Percentage change -3.15	%

Healthcare • Medical Devices • USA • NASD

Peers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC

| Held by: VTI VOO VO QQQ VUG SPY IVV VOT XLV IWP

Scroll to Statements

Index	NDX, S&P 500	P/E	48.10	EPS (ttm)	1.42	Insider Own	1.35%	Shs Outstand	390.70M	Perf Week	-13.81%
Market Cap	26.78B	Forward P/E	27.69	EPS next Y	2.47	Insider Trans	-1.13%	Shs Float	385.48M	Perf Month	-20.66%
Income	576.20M	PEG	2.13	EPS next Q	0.32	Inst Own	92.82%	Short Float	2.56%	Perf Quarter	-12.60%
Sales	4.03B	P/S	6.64	EPS this Y	23.15%	Inst Trans	-1.13%	Short Ratio	2.60	Perf Half Y	-0.03%
Book/sh	5.38	P/B	12.73	EPS next Y	22.53%	ROA	9.04%	Short Interest	9.87M	Perf Year	-48.49%
Cash/sh	6.60	P/C	10.38	EPS next 5Y	22.63%	ROE	27.63%	52W Range	62.34 - 142.00	Perf YTD	-11.88%
Dividend Est.	-	P/FCF	42.46	EPS past 5Y	39.06%	ROI	16.64%	52W High	-51.74%	Beta	1.49
Dividend TTM	-	Quick Ratio	1.28	Sales past 5Y	22.46%	Gross Margin	60.46%	52W Low	9.93%	ATR (14)	3.01
Dividend Ex-Date	-	Current Ratio	1.47	EPS Y/Y TTM	4.24%	Oper. Margin	14.88%	RSI (14)	22.53	Volatility	4.25% 3.39%
Employees	10300	Debt/Eq	1.23	Sales Y/Y TTM	11.34%	Profit Margin	14.29%	Recom	1.54	Target Price	103.45
Option/Short	Yes / Yes	LT Debt/Eq	0.65	EPS Q/Q	-39.07%	Payout	0.00%	Rel Volume	0.63	Prev Close	70.76
Sales Surprise	0.39%	EPS Surprise	-6.09%	Sales Q/Q	7.64%	Earnings	Feb 13 AMC	Avg Volume	3.79M	Price	68.53
SMA20	-17.66%	SMA50	-18.23%	SMA200	-18.60%	Trades		Volume	1,485,574	Change	-3.15%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580
Oct-18-21	Downgrade	Guggenheim	Buy → Neutral
Jul-21-21	Resumed	Cowen	Outperform	$540 → $525
May-28-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$380

Show Previous Ratings

Mar-11-25 02:15PM	Analysts say Dexcoms FDA warning unlikely to impact 2025 revenue (Medical Device Network)
05:07AM	Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) (StockStory)
Mar-10-25 07:31PM	Analyst Report: DexCom, Inc. (Morningstar Research) -9.15%
04:29PM	Why Dexcom Is On A Six-Day Losing Spree But This Analyst Isn't Worried (Investor's Business Daily)
11:53AM	Top Stock Movers Now: Tesla, DexCom, Strategy, and More (Investopedia)
10:15AM	Loading…
10:15AM	DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter (Investopedia)
08:30AM	Dexcom Appoints Rene Gal to Board of Directors (Business Wire)
02:57AM	Dexcom receives warning letter based on FDA inspections of 2 plants (MedTech Dive)
Mar-08-25 08:17AM	Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now? (Insider Monkey)
Mar-07-25 05:51PM	Dexcom receives FDA warning letter for two U.S. manufacturing facilities (Reuters) -9.15%
05:33PM	DexCom Gets FDA Warning Letter After Inspections of Facilities (The Wall Street Journal)
Mar-01-25 06:14PM	3 Growth Stocks to Buy and Hold Forever (Motley Fool)
Feb-27-25 08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
04:05AM	Reflecting On Patient Monitoring Stocks Q4 Earnings: DexCom (NASDAQ:DXCM) (StockStory)
Feb-26-25 04:32AM	Got $200? 2 Healthcare Stocks to Buy and Hold Forever (Motley Fool)
07:30AM	Loading…
Feb-25-25 07:30AM	Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors (GlobeNewswire)
Feb-18-25 03:10PM	Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts? (Insider Monkey)
Feb-14-25 03:04PM	Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom (Benzinga) +5.92%
09:05AM	Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble (Investor's Business Daily)
02:20AM	DexCom Inc (DXCM) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Margin Challenges (GuruFocus.com)
12:08AM	Analyst Report: DexCom, Inc. (Morningstar Research)
Feb-13-25 09:45PM	DexCom (DXCM) Q4 2024 Earnings Call Transcript (Motley Fool)
05:56PM	Informatica CEO on earnings, top trading themes: Asking for a Trend (Yahoo Finance Video)
05:30PM	Here's What Key Metrics Tell Us About DexCom (DXCM) Q4 Earnings (Zacks)
05:22PM	GameStop, Twilio, DexCom: After-hours movers (Yahoo Finance Video)
05:15PM	DexCom (DXCM) Misses Q4 Earnings Estimates (Zacks)
05:10PM	DexComs (NASDAQ:DXCM) Q4: Beats On Revenue (StockStory)
04:41PM	Dexcom Fumbles In The Fourth Quarter As Profit Misses Forecasts By A Nickel (Investor's Business Daily)
04:19PM	DexCom: Q4 Earnings Snapshot (Associated Press Finance)
04:12PM	Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations (Investor's Business Daily)
04:02PM	Loading…
04:02PM	Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results (Business Wire)
Feb-12-25 09:13AM	Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy? (Insider Monkey)
08:07AM	DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-10-25 09:16AM	Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Feb-06-25 10:01AM	DexCom (DXCM) Q4 Earnings Preview: What's in the Cards? (Zacks)
09:30AM	Should You Buy DexCom Stock Before Feb. 13? (Motley Fool)
Feb-04-25 08:15AM	Heres Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM) (Insider Monkey)
Feb-03-25 09:15AM	Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade (Motley Fool)
08:45AM	Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years (Motley Fool)
Jan-30-25 08:30AM	Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time. (Business Wire)
Jan-20-25 12:55PM	How Dexcom and URA are unifying two distinct market sectors (Medical Device Network)
Jan-16-25 07:28PM	Analyst Report: DexCom, Inc. (Morningstar Research) +5.52%
06:46PM	Why DexCom, Inc. (DXCM) Is Skyrocketing (Insider Monkey)
05:21PM	S&P 500 Gains and Losses Today: UnitedHealth Stock Ails as Results Fall Short (Investopedia)
12:14PM	Baird raises DexCom stock to outperform, target to $104 (Investing.com)
05:22AM	2 Healthcare Stocks to Buy Hand Over Fist in January (Motley Fool)
Jan-15-25 05:50AM	Dexcom CEO talks Stelo sensor launch, OTC strategy (MedTech Dive)
Jan-14-25 07:38AM	JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue (Medical Device Network)
Jan-13-25 07:30AM	Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook (Business Wire)
Jan-09-25 08:37AM	Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market. (Investor's Business Daily)
Jan-08-25 04:35PM	Why Is Jim Cramer Mystified by DexCom, Inc. (DXCM)s Earnings Miss and Competitive Challenges? (Insider Monkey)
08:30AM	3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025 (Motley Fool)
Jan-07-25 08:30AM	Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-04-25 07:45AM	These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024 (Motley Fool)
Jan-02-25 06:26AM	Abbott, Dexcom settle glucose monitor patent lawsuits (MedTech Dive)
Jan-01-25 09:37AM	The 5 worst performing stocks on the Nasdaq 100 in 2024 (TheStreet)
Dec-25-24 10:15AM	Abbott, DexCom settlement not a complete surprise, says Wells Fargo (TipRanks)
05:30AM	DexCom, Abbott agree to settle patent litigation (TipRanks)
Dec-23-24 04:56PM	DexCom, Abbott Agree to Settlement in Patent Litigation (The Wall Street Journal)
06:28AM	DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock? (Zacks)
Dec-21-24 06:45AM	1 Reason to Sell DexCom Stock, and 1 Reason to Buy (Motley Fool)
Dec-20-24 04:48PM	S&P 500 Gains and Losses Today: Index Rebounds After Encouraging Inflation Data (Investopedia) +5.57%
Dec-18-24 11:52AM	Dexcom implements GenAI into glucose biosensor devices (Medical Device Network)
07:07AM	AI-Driven Glucose Biosensing: Dexcoms (DXCM) Path To A Comeback (Insider Monkey)
06:13AM	Dexcom adds generative AI to over-the-counter CGMs (MedTech Dive)
Dec-17-24 09:00AM	Dexcom Launches the First Generative AI Platform in Glucose Biosensing (Business Wire)
08:00AM	Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM (Business Wire)
06:45AM	Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds? (Insider Monkey)
Dec-10-24 11:21AM	Dexcom shares up as Diabetes Association updates guidelines (Investing.com)
Dec-02-24 09:12AM	3 Reasons to Buy DexCom Stock Like There's No Tomorrow (Motley Fool)
Nov-28-24 07:45AM	2 Excellent Healthcare Stocks to Hold Through the Next Decade (Motley Fool)
Nov-27-24 09:28AM	Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024? (Insider Monkey)
Nov-26-24 09:50AM	Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-25-24 05:21PM	DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care (Insider Monkey) +6.87%
Nov-24-24 10:15AM	2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest (Motley Fool)
Nov-23-24 09:00AM	The Oura ring, the best Black Friday deals, and the safest states: Business news roundup (Quartz)
05:00AM	Oura ring's new trick, SpaceX smack talk, and Black Friday deals: The week's most popular stories (Quartz)
Nov-22-24 09:54AM	Heres Why DexCom (DXCM) Declined In Q3 (Insider Monkey)
05:00AM	Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundup (Quartz)
05:00AM	Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup (Quartz)
Nov-20-24 06:00AM	Dexcom invests $75M in ura, agrees to integrate smart rings and CGMs (MedTech Dive)
Nov-19-24 05:45PM	DexCom Pairs Its Glucose Monitor With URAs Smart Ring (Barrons.com)
11:15AM	Dexcom invests $75m in URA to forge partnership (Medical Device Network)
07:51AM	Oura CEO on new partnership with Dexcom (CNBC TV)
06:00AM	The Oura ring will soon help you monitor your blood sugar (Quartz)
06:00AM	Dexcom and URA Announce Strategic Partnership (Business Wire)
06:00AM	Dexcom and OURA Announce Strategic Partnership (Business Wire)
Nov-15-24 12:12PM	DexCom, Inc. (DXCM): Among 12 High Growth Large Cap Stocks to Buy Now (Insider Monkey)
Nov-14-24 06:00AM	Dexcom Helps People With Diabetes Take the First Step to Discover What Theyre Made Of on World Diabetes Day (Business Wire)
Nov-12-24 04:43PM	S&P 500 Gains and Losses Today: Mosaic Stock Slumps After Earnings Miss (Investopedia) +5.73%
Nov-08-24 10:15AM	1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years (Motley Fool)
Nov-01-24 12:29PM	DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss (Insider Monkey)
Oct-30-24 03:02PM	Is DexCom, Inc. (NASDAQ:DXCM) The Worst Performing S&P 500 Stock In 2024? (Insider Monkey)
12:44PM	Heres Why DexCom (DXCM) Detracted in Q3 (Insider Monkey)
09:14AM	Multiple Headwinds Dragged DexCom (DXCM) in Q3 (Insider Monkey)
Oct-28-24 09:50AM	Here's Why DexCom (DXCM) is a Strong Momentum Stock (Zacks)
Oct-26-24 04:02AM	Decoding DexCom Inc (DXCM): A Strategic SWOT Insight (GuruFocus.com)
Oct-25-24 05:53PM	Why DexCom Stock Flopped on Friday (Motley Fool)
04:26PM	Dexcom Pares Steep Losses Despite A Key Exec Departure Amid Stelo Launch (Investor's Business Daily)
12:05PM	Dexcom Reverses Losses Despite A Key Exec Departure Amid Stelo Launch (Investor's Business Daily)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 10 '25	Sale	73.83	7,000	516,830	135,482	Mar 11 07:17 PM
JEREME SYLVAIN	Officer	Mar 10 '25	Proposed Sale	73.83	7,000	516,830		Mar 10 04:03 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Jan 29 '25	Sale	86.91	2,090	181,650	83,526	Jan 30 06:44 PM
Dolan Matthew Vincent	EVP, Strategy & Corporate Dev	Jan 29 '25	Sale	86.91	1,183	102,820	42,044	Jan 30 06:44 PM
Stern Sadie	EVP, Chief HR Officer	Jan 29 '25	Sale	86.91	2,093	181,911	74,261	Jan 30 06:44 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Jan 29 '25	Sale	86.91	2,634	228,932	268,644	Jan 30 06:44 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 29 '25	Sale	86.91	33,359	2,899,367	319,037	Jan 30 06:43 PM
Stern Sadie	EVP, Chief HR Officer	Dec 16 '24	Sale	76.87	424	32,593	70,768	Dec 17 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Dec 16 '24	Sale	76.87	744	57,191	80,030	Dec 17 04:15 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Dec 16 '24	Sale	76.87	744	57,191	264,171	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Sale	76.87	1,000	76,870	23,349	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Proposed Sale	76.87	1,000	76,870		Dec 16 11:56 AM
Stern Sadie	EVP, Chief HR Officer	Nov 20 '24	Sale	74.73	4,259	318,275	71,192	Nov 22 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Nov 15 '24	Sale	75.51	3,500	264,285	80,774	Nov 18 04:12 PM
JEREME SYLVAIN	Officer	Nov 15 '24	Proposed Sale	75.51	3,500	264,285		Nov 15 04:04 PM
Heller Bridgette P	Director	Sep 16 '24	Sale	70.00	1,000	70,000	24,349	Sep 17 04:17 PM
Heller Bridgette P	Director	Sep 16 '24	Proposed Sale	70.00	1,000	70,000		Sep 16 09:53 AM
Stern Sadie	EVP, Chief HR Officer	Sep 09 '24	Sale	69.15	426	29,458	75,451	Sep 11 07:05 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 09 '24	Sale	69.15	746	51,586	84,274	Sep 11 07:05 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Sep 09 '24	Sale	69.15	746	51,586	264,915	Sep 11 07:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 30 '24	Sale	70.00	686	48,020	65,636	Sep 03 04:22 PM
MICHAEL BROWN	Officer	Aug 30 '24	Proposed Sale	70.00	686	48,020		Aug 30 04:32 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 31 '24	Sale	69.55	652	45,347	66,249	Aug 01 07:23 PM
MICHAEL BROWN	Officer	Jul 31 '24	Proposed Sale	69.55	652	45,347		Jul 31 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Jun 28 '24	Sale	114.29	659	75,317	66,901	Jun 28 05:34 PM
FOLETTA MARK G	Director	Jun 18 '24	Sale	116.79	3,306	386,122	56,398	Jun 20 04:50 PM
FOLETTA MARK G	Director	Jun 17 '24	Sale	117.26	2,694	315,907	59,704	Jun 20 04:50 PM
Heller Bridgette P	Director	Jun 14 '24	Sale	113.55	1,000	113,550	25,349	Jun 18 07:16 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jun 10 '24	Sale	115.05	745	85,713	84,948	Jun 11 06:39 PM
Stern Sadie	EVP Chief HR Officer	Jun 10 '24	Sale	115.05	427	49,127	75,877	Jun 11 06:39 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jun 10 '24	Sale	115.05	745	85,713	265,577	Jun 11 06:38 PM
Brown Michael Jon	EVP Chief Legal Officer	May 31 '24	Sale	119.24	652	77,744	67,560	May 31 05:27 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	May 15 '24	Sale	126.58	2,423	306,703	40,075	May 16 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Apr 30 '24	Sale	126.25	629	79,411	68,212	May 02 05:07 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	Apr 15 '24	Sale	137.81	1,990	274,242	42,377	Apr 16 04:16 PM
SAYER KEVIN R	President CEO and Chairman	Apr 08 '24	Sale	138.30	49,633	6,864,136	283,893	Apr 10 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 28 '24	Sale	140.04	2,624	367,472	68,682	Mar 29 07:30 PM
Stern Sadie	EVP Chief Human Resources	Mar 25 '24	Sale	140.00	4,137	579,180	76,304	Mar 26 04:46 PM
Dolan Matthew Vincent	EVP Strategy & Corp Dev	Mar 15 '24	Sale	130.21	4,203	547,259	44,367	Mar 19 04:55 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience